Literature DB >> 34906939

Biologics for episodic and chronic migraines.

Sandra Trkulja1, Trudy Huyghebaert2, Joey Ton3, Clark Svrcek4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34906939      PMCID： PMC8670648          DOI： 10.46747/cfp.6712911

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  7 in total

Review 1.  Guideline for primary care management of headache in adults.

Authors:  Werner J Becker; Ted Findlay; Carmen Moga; N Ann Scott; Christa Harstall; Paul Taenzer
Journal:  Can Fam Physician       Date:  2015-08       Impact factor: 3.275

Review 2.  Topiramate for the prophylaxis of episodic migraine in adults.

Authors:  Mattias Linde; Wim M Mulleners; Edward P Chronicle; Douglas C McCrory
Journal:  Cochrane Database Syst Rev       Date:  2013-06-24

3.  Safety and Efficacy of Fremanezumab for the Prevention of Migraine: A Meta-Analysis From Randomized Controlled Trials.

Authors:  Bixi Gao; Nan Sun; Yanbo Yang; Yue Sun; Mingjia Chen; Zhouqing Chen; Zhong Wang
Journal:  Front Neurol       Date:  2020-05-19       Impact factor: 4.003

4.  Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine - an updated systematic review and meta-analysis.

Authors:  Hong Deng; Gai-Gai Li; Hao Nie; Yang-Yang Feng; Guang-Yu Guo; Wen-Liang Guo; Zhou-Ping Tang
Journal:  BMC Neurol       Date:  2020-02-15       Impact factor: 2.474

5.  Erenumab safety and efficacy in migraine: A systematic review and meta-analysis of randomized clinical trials.

Authors:  Changyu Zhu; Jianmei Guan; Hua Xiao; Weinan Luo; Rongsheng Tong
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

6.  Preventive effects of galcanezumab in adult patients with episodic or chronic migraine are persistent: data from the phase 3, randomized, double-blind, placebo-controlled EVOLVE-1, EVOLVE-2, and REGAIN studies.

Authors:  Stefanie Förderreuther; Qi Zhang; Virginia L Stauffer; Sheena K Aurora; Miguel J A Láinez
Journal:  J Headache Pain       Date:  2018-12-29       Impact factor: 7.277

7.  European headache federation consensus on the definition of resistant and refractory migraine : Developed with the endorsement of the European Migraine & Headache Alliance (EMHA).

Authors:  Simona Sacco; Mark Braschinsky; Anne Ducros; Christian Lampl; Patrick Little; Antoinette Maassen van den Brink; Patricia Pozo-Rosich; Uwe Reuter; Elena Ruiz de la Torre; Margarita Sanchez Del Rio; Alexandra J Sinclair; Zaza Katsarava; Paolo Martelletti
Journal:  J Headache Pain       Date:  2020-06-16       Impact factor: 7.277
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.